A study of a new device for leaking heart valves in LVAD patients
Part of Heart & circulation clinical trials.
This trial tests a new device to treat a leaking aortic valve in people who already have a left ventricular assist device (LVAD). The goal is to fix the leak without open-heart surgery, which may improve how well the LVAD works and reduce symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a left ventricular assist device (LVAD) and a moderate-to-severe leak in your aortic valve that causes symptoms like shortness of breath or fatigue (NYHA class II or higher).
- Your medical team must agree that open-heart surgery would be too risky for you.
- You cannot have had a previous aortic valve replacement or repair.
- You must not have other serious heart valve problems, active infections, or certain blood disorders.
- You need to be able to take blood thinners (like aspirin or clopidogrel) and not have allergies to the device materials.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new, less invasive device called J-Valve for people with severe aortic regurgitation (a leaky aortic valve). It is placed through a tube in the leg artery, avoiding open-heart surgery, and may help those who are at high risk for surgery.
This trial compares a new catheter-based valve (J-Valve) with open-heart surgery for people with severe aortic regurgitation, a condition where the aortic valve doesn't close tightly. It aims to see which treatment is safer and more effective.
This trial tests a new type of aortic heart valve (PoliaValve) for people with severe aortic valve disease who need valve replacement surgery. If you qualify, you will receive the experimental valve and be followed for one year to see how well it works.
This study is for people with a severe leaking aortic valve (aortic regurgitation) who are too high-risk for open-heart surgery. It tracks how well a less-invasive valve replacement (TAVI) using the JenaValve or J-Valve works for them.
This trial studies a less invasive heart valve procedure that places a new valve through a catheter, to treat severe leakage of the aortic valve. It may help people who have symptoms or heart enlargement and who are at higher risk for open-heart surgery.
This trial tests a new device designed to fix a leaky mitral valve in people with heart failure. It may help you breathe easier and feel less tired if your valve leak is severe and medicines have not been enough.
Hear when a new Aortic Valve Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.